PMID: 15226609Jul 1, 2004Paper

The difference of angiogenesis in human lung adenocarcinoma cell lines with different metastatic potency

Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
Datong ZouS Kudoh

Abstract

We investigated the ability of angiogenesis in PC9/F9 cells (from a highly metastatic human lung adenocarcinoma cell line) as compared with PC9 cells (from a low metastatic human lung adenocarcinoma cell line). In vivo tumor growth assay using BALB/c nude mice (7 mice/group), showed that the tumor volume of PC9/F9 cells on day 35 (230.7+/-31.3 mm(3)) was significantly larger than that of PC9 cells (90.9+/-24.7 mm(3)) (p<0.001). However, there was no significant difference between PC9/F9 cells and PC9 cells in an in vitro growth assay. In a dorsal air sac assay (DAS assay) using ICR mice (3 mice/group), PC9/F9 cells (4.7+/-1.2 vessels) showed stronger neovascurizationin in compared with PC9 cells (0.3+/-0.4 vessels) (p<0.05). In an enzyme linked immunosorbent assay (ELISA) and Western blotting analysis there were no significant differences between PC9/F9 cells and PC9 cells in the protein expression of vascular endothelial growth factor (VEGF). There was no significant difference between the gene expression levels of PC9/F9 cells and PC9 cells on cDNA array analysis. Matrix metalloproteinase-2 (MMP-2) activity in PC9/F9 cells was remarkably stronger than that of PC9 cells in Gelatin Zymography. From these results, we considered ...Continue Reading

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Jan 10, 1980·Nature·G Poste, I J Fidler
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W JiangI B Weinstein
Feb 1, 1997·Endocrine Reviews·N Ferrara, T Davis-Smyth
Aug 22, 2000·The Journal of Investigative Dermatology·U B HofmannD J Ruiter
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·J G RozicP K Lala
Aug 17, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A GemmaS Kudoh
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Annamaria RapellaMaria Carla Bosco
Nov 27, 2002·Surgical Oncology·Jiang Liu, Michael R Johnston

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.